Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Contraception and Contraceptive Drugs

Free Subscription 25.10.2021 2 Am J Obstet Gynecol 21 Contraception 1 Gynecol Endocrinol 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. KRAMER RD, Higgins JA, Everett B, Turok DK, et al
   A Prospective Analysis of the Relationship Between Sexual Acceptability and Contraceptive Satisfaction Over Time.
   Am J Obstet Gynecol. 2021 Oct 14. pii: S0002-9378(21)01109.
   PubMed         Abstract available
   
   
2. MONIZ MH, Dalton VK, Smith RD, Owens LE, et al
   Feasibility and Acceptability of a Toolkit-Based Process to Implement Patient-Centered, Immediate Postpartum Long-Acting Reversible Contraception Services.
   Am J Obstet Gynecol. 2021 Oct 13. pii: S0002-9378(21)01110.
   PubMed         Abstract available
   
   

   
   Contraception

3. GILLIAM ML, Jensen JT, Eisenberg DL, Thomas MA, et al
   Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years.
   Contraception. 2021;103:444-449.
   PubMed         Abstract available
   
   
4. RAYMOND EG, Anger HA, Chong E, Haskell S, et al
   "False positive" urine pregnancy test results after successful medication abortion.
   Contraception. 2021;103:400-403.
   PubMed         Abstract available
   
   
5. FLYNN AN, Roe AH, Koelper N, McAllister A, et al
   Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss.
   Contraception. 2021;103:404-407.
   PubMed         Abstract available
   
   
6. DRAGOMAN MV, Grossman D, Nguyen MH, Habib N, et al
   Two prophylactic pain management regimens for medical abortion
   Contraception. 2021;103:163-170.
   PubMed         Abstract available
   
   
7. BOUMA-JOHNSTON H, Ponsaran R, Arora KS
   Variation by state in Medicaid sterilization policies for physician reimbursement.
   Contraception. 2021;103:255-260.
   PubMed         Abstract available
   
   
8. NELSON AL, Kaunitz AM, Kroll R, Simon JA, et al
   Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results.
   Contraception. 2021;103:137-143.
   PubMed         Abstract available
   
   
9. GOLDMAN AR, Gerber SR
   Levonorgestrel intrauterine system (IUS) in a patient with uterine didelphys: A case report.
   Contraception. 2021;103:134-135.
   PubMed         Abstract available
   
   
10. CARR BR, Thomas MA, Gangestad A, Eisenberg DL, et al
    Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta(R)) discontinuation.
    Contraception. 2021;103:26-31.
    PubMed         Abstract available
    
    
11. SEIDMAN D, Cavrois M, Hilton JF, Roan NR, et al
    Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: Results of an ex vivo fusion assay.
    Contraception. 2021;103:44-47.
    PubMed         Abstract available
    
    
12. RASMUSSEN KN, Janiak E, Cottrill AA, Stulberg DB, et al
    Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois.
    Contraception. 2021;104:98-103.
    PubMed         Abstract available
    
    
13. DANIEL S, Schulkin J, Grossman D
    Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone.
    Contraception. 2021;104:73-76.
    PubMed         Abstract available
    
    
14. GLASER K, Whitehair J
    Missing mifepristone at tribal health facilities serving native Americans.
    Contraception. 2021;104:36-37.
    PubMed         Abstract available
    
    
15. CLELAND K, Foster AM, Gomez AM, Raymond EG, et al
    Contraception Special Issue on the mifepristone Risk Evaluation and Mitigation Strategy (REMS).
    Contraception. 2021;104:1-3.
    PubMed        
    
    
16. THOMPSON A, Singh D, Ghorashi AR, Donovan MK, et al
    The disproportionate burdens of the mifepristone REMS.
    Contraception. 2021;104:16-19.
    PubMed        
    
    
17. MEURICE ME, Whitehouse KC, Blaylock R, Chang JJ, et al
    Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks' gestation at British Pregnancy Advisory Service: A cross-sectional evaluation.
    Contraception. 2021;104:61-66.
    PubMed         Abstract available
    
    
18. STONE RH, Rafie S
    Medication abortion: Advocating for mifepristone dispensing by pharmacists.
    Contraception. 2021;104:31-32.
    PubMed        
    
    
19. KAYE J, Reeves R, Chaiten L
    The mifepristone REMS: A needless and unlawful barrier to care.
    Contraception. 2021;104:12-15.
    PubMed         Abstract available
    
    
20. SRINIVASULU S, Yavari R, Brubaker L, Riker L, et al
    US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.
    Contraception. 2021;104:92-97.
    PubMed         Abstract available
    
    
21. CALLOWAY D, Stulberg DB, Janiak E
    Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States.
    Contraception. 2021;104:24-28.
    PubMed         Abstract available
    
    
22. LATACK KR, Patel J, Moog D, Spencer D, et al
    Withdrawal method inquiries and user experiences: An analysis of content posted on 4 gendered forums on Reddit.
    Contraception. 2021;104:170-175.
    PubMed         Abstract available
    
    
23. RAIDOO S, Kaneshiro B, Stowers P
    Guam: The US territory where America's day begins but abortion access is still in the dark.
    Contraception. 2021;104:33-35.
    PubMed         Abstract available
    
    

    
    Gynecol Endocrinol

24. ATAKUL T, Tayyar AT, Turan OD, Celik SY, et al
    An assessment of the protective effect of gonadotropin-releasing hormone agonist and antagonist on bleomycin-induced ovarian toxicity in rats.
    Gynecol Endocrinol. 2021;37:46-50.
    PubMed         Abstract available
    
    

    
    PLoS One

25. LIAUW J, Jurgutis J, Nouvet E, Dineley B, et al
    Reproductive healthcare in prison: A qualitative study of women's experiences and perspectives in Ontario, Canada.
    PLoS One. 2021;16:e0251853.
    PubMed         Abstract available
    
    
26. WILLCOX ML, Mubangizi V, Natukunda S, Owokuhaisa J, et al
    Couples' decision-making on post-partum family planning and antenatal counselling in Uganda: A qualitative study.
    PLoS One. 2021;16:e0251190.
    PubMed         Abstract available
    
    
27. KWON SJ, Im YM
    Sexual health knowledge and needs among young adults with congenital heart disease.
    PLoS One. 2021;16:e0251155.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: